← Back to directory
WP
Wellington Partners
Munich, GermanyWebsite ↗
Wellington Partners is a leading European venture capital firm, founded in 1998, that invests in early- and growth-stage life science companies with breakthrough and innovative technologies. The firm supports entrepreneurs in sectors such as therapeutics, medical devices, diagnostics, digital health, and industrial biotechnology.
Last raised
Jul 2024
2y 2mo ago
Latest fund size
$226M
Wellington Partners Life Science Fund V
AUM
$860M
estimated
Funds raised
Capital this firm has raised, newest first
Wellington Partners Life Science Fund V
Jul 2024 · WPLS-V
$226M
Wellington Partners III Technology Fund
Jan 2013
$161.4M
Wellington Partners Life Science Fund IV
Jan 2012 · WPLS IV
$5.4M
Wellington Partners IV Technology
Jan 2008
$285.1M
Wellington Partners Life Science Fund III
Jan 2007 · WPLS III
$5.4M
Wellington Partners II
Jun 2000
$226M
Wellington Partners I
Jan 1998
—
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Sidekick Health | Series B | — | Unknown | source ↗ |
| nyra health | — | — | Unknown | source ↗ |
| Beren Therapeutics | — | — | Jun 2026 | source ↗ |
| Nuclidium | Series B | $117M | May 2026 | source ↗ |
| Hilo Health | — | — | May 2025 | source ↗ |
| AMBOSS | Series C | — | Mar 2025 | source ↗ |
| SciRhom GmbHLead | Series A | $70M | Jul 2024 | source ↗ |
Sources
Where this data came from